/
KMTS
$25.28-$1.07 (-4.05%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.5B
58M shares
52-week range
$13.25 – $30.00
72% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.30%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$3.52
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $7.6M | $27.8M | $59.8M |
| Cost of revenue | $0 | $0 | $18.3M | $27.5M | $35.6M |
| Gross profit | $0 | $0 | −$10.7M | $362.0K | $24.2M |
| Gross margin | — | — | -139.6% | 1.3% | 40.5% |
| R&D | $22.8M | $18.8M | $15.8M | $15.5M | $15.7M |
| Operating income | −$29.3M | −$32.7M | −$80.4M | −$85.1M | −$106.4M |
| EBITDA | −$28.8M | −$32.3M | −$73.7M | −$76.3M | −$98.0M |
| Net income | −$29.5M | −$34.1M | −$84.2M | −$94.1M | −$113.8M |
| Net margin | — | — | -1104.0% | -338.4% | -190.3% |
| EPS (diluted) | -0.59 | -0.69 | -1.75 | -2.04 | -5.13 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $133M | $-2.20 | $-2.41–$-1.94 | 4 |
| 2028 | $191M | $-1.77 | $-2.08–$-1.42 | 6 |
| 2029 | $269M | $-1.21 | $-1.32–$-1.10 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$4.30
Price
$25.28
Implied downside
-83%
Peer comparison
Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
www.kestramedical.com- Employees
- 330
- IPO / List date
- Mar 6, 2025
- HQ
- KIRKLAND, WA
Held by traders on TradeandTell
No one on the platform currently holds KMTS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in KMTS as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded KMTS yet.
